Press release for the unaudited financial results for the quarter ended September 30, 2026.

November 2, 2026 To, To, The Corporate Relations Department The Listing Department The BSE Limited The National Stock Exchange of India Limited Department of Corporate Services Exchange Plaza, Plot No. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400001. Mumbai – 400051 Ref:- Scrip Code:- 500126 Ref:- Symbol:- PGHL Dear Sir / Madam, Sub:- Press release for Unaudited Financial Results for Quarter ended September 30, 2026 We are enclosing herewith the Press Release, regarding the Unaudited Financial Results for Quarter ended September 30, 2026, approved at a meeting of the Board of Directors of the Company held today. Kindly take the same on record. Thanking you. Yours faithfully, For Procter & Gamble Health Limited Flavia Machado Authorized Signatory Business Use Procter & Gamble Health Announces Second Quarter Results Sales up 18% and PAT up 26% for the quarter ended September 30, 2026 Mumbai, November 2, 2026: Procter & Gamble Health Ltd. (“the Company”) today announced its financial results for the second quarter ended September 30, 2026. The Company delivered sales of ₹376 crores, up 18% versus a year ago, driven by strong brand fundamentals, superior retail execution, positive consumer response to new innovations and strengthened go-to-market capabilities. Reported Profit After Tax (PAT) stood at ₹112 crores, up 26% versus a year ago, led by growth in sales and productivity across the value chain. Milind Thatte, Managing Director, P&G Health India, said, “We have delivered another strong quarter with double-digit topline and bottom-line growth, continuing the momentum of the previous quarters. The growth reflects the positive response of consumers, patients and health care professionals (HCPs) to our science-backed superior healthcare products and innovations amid growing consumer focus on preventive health. It also demonstrates the impact of our strong retail execution, new consumer communication and HCP awareness initiatives and strengthened go-to-market and supply chain capabilities. We are delivering balanced growth and value creation for all our stakeholders, driven by our strategy that is centred on a focused portfolio of quality, trusted and highly recommended brands where performance drives brand choice, superiority (across product, package, brand communication, retail execution and value), constructive disruption, productivity, and an agile accountable organization.” About Procter & Gamble Health Limited: Procter & Gamble Health Limited is one of India’s largest vitamins, minerals, and supplements (VMS) companies manufacturing and marketing VMS products for a healthy lifestyle and improved quality of life, including Neurobion, Livogen, SevenSeas, Evion, Polybion and Nasivion. Please visit www.pghealthindia.com for the latest news and information about Procter & Gamble Health Limited and its brands. About Procter & Gamble: P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Ambi Pur®, Ariel®, Gillette®, Braun®, Head & Shoulders®, Olay®, Oral-B®, Pampers®, Pantene®, Herbal Essences®, Tide®, Vicks®, and Whisper®. P&G operates in approximately 70 countries worldwide. CONTACTS Media Contacts - Procter & Gamble Health Limited: Vishesh Bohre | bohre.v@pg.com Agency Contact – Madison PR Malika Bhavnani | malika.bhavnani@madisonpr.in